Articles by Disease (Parkinsonian Disorders)

Mitochondrial Toxins in Basal Ganglia Disorders: From Animal Models to Therapeutic Strategies

Journal: Current Neuropharmacology
Volume: 4
Page: 69-75
Author(s): P. Bonsi, D. Cuomo, G. Martella, G. Sciamanna, M. Tolu, P. Calabresi, G. Bernardi and A. Pisani

Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors

Journal: Current Neurovascular Research
Volume: 2
Page: 425-446
Author(s): Kenneth Maiese, Zhao Z. Chong and Faqi Li

The Emerging Role of Coenzyme Q-10 in Aging, Neurodegeneration, Cardiovascular Disease, Cancer and Diabetes Mellitus

Journal: Current Neurovascular Research
Volume: 2
Page: 447-459
Author(s): Muralikrishnan Dhanasekaran and Jun Ren

Neuronal Nicotinic Receptors and Neuroprotection: Newer Ligands May Help us Understand their Role in Neurodegeneration

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2
Page: 455-471
Author(s): M. J. O'Neill, P. Astles, C. P. Dell, M. Keenan, T. K. Murray, V. Lakics, N. P. Visanji and S. Duty

Current Clinical Applications of In Vivo Magnetic Resonance Spectroscopy and Spectroscopic Imaging

Journal: Current Medical Imaging
Volume: 1
Page: 271-302
Author(s): Margaret R. Lentz, Jennifer L. Taylor, D. A. Feldman and Leo L. Cheng

Reactive Astrocytes as Potential Manipulation Targets in Novel Cell Replacement Therapy of Parkinsons Disease

Journal: Current Drug Targets
Volume: 6
Page: 821-833
Author(s): L- W. Chen, K- L. Yung and Y- S. Chan

Small Neuroscience: The Nanostructure of the Central Nervous System and Emerging Nanotechnology Applications

Journal: Current Nanoscience
Volume: 1
Page: 225-236
Author(s): Gabriel A. Silva

PET and SPECT Exploration of Central Monoaminergic Transporters for the Development of New Drugs and Treatments in Brain Disorders

Journal: Current Pharmaceutical Design
Volume: 11
Page: 3237-3245
Author(s): D. Guilloteau and S. Chalon

Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 2 (mGluR2)

Journal: Current Topics in Medicinal Chemistry
Volume: 5
Page: 869-884
Author(s): Michael T. Rudd and John A. McCauley

Targeting the Metabotropic Glutamate Receptor mGluR4 for the Treatment of Diseases of the Central Nervous System

Journal: Current Topics in Medicinal Chemistry
Volume: 5
Page: 885-895
Author(s): Michael J. Marino, J. F. Hess and Nigel Liverton